| Name: | 3-Deoxy-3-acetyl abiraterone-3-ene |
| Catalogue No. | VE006955 |
| CAS No. | N/A |
| Molecular Formula | C26H31NO |
| Molecular Weight | 373.5 |
| Status | In-Stock |
| IUPAC Name | 1-[17-(Pyridin-3-yl)androsta-3,5,16-trien-3-yl]ethanone |
| Description | 3-Deoxy-3-acetyl abiraterone-3-ene (CAS No: N/A) or 1-[17-(Pyridin-3-yl)androsta-3,5,16-trien-3-yl]ethanone,it is poorly absorbed and is susceptible to hydrolysis by esterases and is an orally active inhibitor of the steroidal enzyme CYP17A1 that is used in the treatment of prostate cancer. |
| References | Goldberg, Tamara, and Evangelina Berrios-Colon. “Abiraterone (Zytiga), a Novel Agent for the Management of Castration-Resistant Prostate Cancer.” Pharmacy and Therapeutics, vol. 38, no. 1, 1 Jan. 2013, pp. 23–26, www.ncbi.nlm.nih.gov/pmc/articles/PMC3628169/. Accessed 31 Jan. 2022. |
